Jan'05 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | $30.6B | $37.0B | $43.8B | $76.3B | $87.5B | $98.2B | $95.8B | $107.1B | $123.1B | $126.8B | $139.4B | $153.3B | $177.5B | $184.8B | $194.6B | $256.8B | $268.7B | $292.1B | $322.5B | $357.8B |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, CVS Health Corporation's last 12-month Revenue is $368.9B, based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, CVS Health Corporation's Revenue growth was 6.1%. The average annual Revenue growth rates for CVS Health Corporation have been 10.8% over the past three years, 8.5% over the past five years.
Over the last year, CVS Health Corporation's Revenue growth was 6.1%, which is higher than industry growth of 0.1%. It indicates that CVS Health Corporation's Revenue growth is Good.